Radioligand cancer therapy forces manufacturers to race the clock

$ 9.00

5 (380) In stock

Radioligand therapy is a 'game -hanger' for cancer treatment, but it forces manufacturers to race against a ticking clock.
Radioligand therapy is a 'game -hanger' for cancer treatment, but it forces manufacturers to race against a ticking clock.

PDF) Case Report: Long-term complete response to PSMA-targeted radioligand therapy and abiraterone in a metastatic prostate cancer patient

Radionuclide Targeted Alpha Therapy, Actinium Radiopharmaceuticals

Addressing Challenges and Controversies in the Management of Prostate Cancer with Multidisciplinary Teams

Radioligand Therapy

Cancer-fighting nuclear medicine firms find home in central Indiana – Indianapolis Business Journal

Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer - ScienceDirect

Recent advances and future perspectives in the therapeutics of prostate cancer, Experimental Hematology & Oncology

Theranostics and radiopharmaceuticals in cancer treatment - ScienceDirect

IJMS, Free Full-Text

Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation - ScienceDirect

Recent advances and futuristic potentials of nano-tailored doxorubicin for prostate cancer therapy - ScienceDirect

PDF) From Radioimmunodetection to Radiomolecular Precision Oncology Via Radionanotargeting by Intelligent Multidisciplinary Radiotheragnostic Nanoparticles

News NorthStar Medical Radioisotopes, LLC

Jeevan Virk on LinkedIn: #aacr #aacr #cancer #theranostics #radioligandtherapy #novartis #rlt

Exclusive Interview with Focus-X Therapeutics: Achieving Successful Acquisition within Two Years of Establishment, What Makes This Radiopharmaceutical Start-Up Stand Out?